Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

529 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Marfella R, Sardu C, D'Onofrio N, Fumagalli C, Scisciola L, Sasso FC, Siniscalchi M, Marfella LV, D'Andrea D, Minicucci F, Signoriello G, Cesaro A, Trotta MC, Frigé C, Prattichizzo F, Balestrieri ML, Ceriello A, Calabrò P, Mauro C, Del Viscovo L, Paolisso G. Marfella R, et al. Among authors: calabro p. BMC Med. 2023 Feb 24;21(1):71. doi: 10.1186/s12916-023-02781-2. BMC Med. 2023. PMID: 36829203 Free PMC article.
Peri-procedural tight glycemic control during early percutaneous coronary intervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction.
Marfella R, Sasso FC, Siniscalchi M, Paolisso P, Rizzo MR, Ferraro F, Stabile E, Sorropago G, Calabrò P, Carbonara O, Cinquegrana G, Piscione F, Ruocco A, D'Andrea D, Rapacciuolo A, Petronella P, Bresciani A, Rubino P, Mauro C, Paolisso G. Marfella R, et al. Among authors: calabro p. J Clin Endocrinol Metab. 2012 Aug;97(8):2862-71. doi: 10.1210/jc.2012-1364. Epub 2012 May 25. J Clin Endocrinol Metab. 2012. PMID: 22639289 Clinical Trial.
The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.
Gragnano F, Sperlongano S, Golia E, Natale F, Bianchi R, Crisci M, Fimiani F, Pariggiano I, Diana V, Carbone A, Cesaro A, Concilio C, Limongelli G, Russo M, Calabrò P. Gragnano F, et al. Among authors: calabro p. Mediators Inflamm. 2017;2017:5620314. doi: 10.1155/2017/5620314. Epub 2017 May 28. Mediators Inflamm. 2017. PMID: 28634421 Free PMC article. Review.
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units Registry.
De Luca L, Musumeci G, Leonardi S, Gonzini L, Cavallini C, Calabrò P, Mauro C, Cacciavillani L, Savonitto S, De Servi S; EYESHOT Investigators. De Luca L, et al. Among authors: calabro p. J Cardiovasc Med (Hagerstown). 2017 Aug;18(8):580-589. doi: 10.2459/JCM.0000000000000533. J Cardiovasc Med (Hagerstown). 2017. PMID: 28639987
Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group".
Scherillo M, Cirillo P, Formigli D, Bonzani G, Calabrò P, Capogrosso P, Farina R, Lanzillo T, Mascia F, Mauro C, Tuccillo B, Bellis A, Bianchi R, Cimmino G, Piro O, Ravera A, Scotto di Uccio F, Tammaro P, Vetrano A, Trimarco B. Scherillo M, et al. Among authors: calabro p. Angiology. 2017 Aug;68(7):598-607. doi: 10.1177/0003319716676721. Epub 2016 Nov 12. Angiology. 2017. PMID: 28660806
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment.
Marfella R, Sardu C, Calabrò P, Siniscalchi M, Minicucci F, Signoriello G, Balestrieri ML, Mauro C, Rizzo MR, Paolisso G, Barbieri M. Marfella R, et al. Among authors: calabro p. Diabetes Obes Metab. 2018 Mar;20(3):723-729. doi: 10.1111/dom.13122. Epub 2017 Nov 3. Diabetes Obes Metab. 2018. PMID: 28950045
Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience.
Gragnano F, Natale F, Concilio C, Fimiani F, Cesaro A, Sperlongano S, Crisci M, Limongelli G, Calabrò R, Russo M, Golia E, Calabrò P. Gragnano F, et al. Among authors: calabro r, calabro p. J Cardiovasc Med (Hagerstown). 2018 Feb;19(2):75-77. doi: 10.2459/JCM.0000000000000611. J Cardiovasc Med (Hagerstown). 2018. PMID: 29251697 No abstract available.
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis.
Marfella R, Sardu C, Balestrieri ML, Siniscalchi M, Minicucci F, Signoriello G, Calabrò P, Mauro C, Pieretti G, Coppola A, Nicoletti G, Rizzo MR, Paolisso G, Barbieri M. Marfella R, et al. Among authors: calabro p. Diabetol Metab Syndr. 2018 Jan 3;10:1. doi: 10.1186/s13098-017-0304-3. eCollection 2018. Diabetol Metab Syndr. 2018. PMID: 29308090 Free PMC article.
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience.
Sperlongano S, Gragnano F, Natale F, D'Erasmo L, Concilio C, Cesaro A, Golia E, Crisci M, Sperlongano R, Fimiani F, Russo M, Arca M, Limongelli G, Calabrò P. Sperlongano S, et al. Among authors: calabro p. J Cardiovasc Med (Hagerstown). 2018 Mar;19(3):83-90. doi: 10.2459/JCM.0000000000000620. J Cardiovasc Med (Hagerstown). 2018. PMID: 29389816
529 results